Twynstar showing robust sales in May
Published: 2012-06-25 06:57:00
Updated: 2012-06-25 06:57:00
Boehringer Ingelheim’s antihypertensive Twynstar has expand a bigger market share at the brisk pace as its sales in May stood at 4.8 billion won, according to Yakup.com, a pharmaceutical information provider. The drug posted 33 billion won in sales last year.
Market observers said the robust s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
